drugset / Trial / NCT00486291
Study of VI-0521 Compared to Placebo in the Glycemic Management of Obese Diabetics
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to evaluate the efficacy and safety of VI-0521 compared to placebo in the glycemic management of obese diabetic adults.
Timeline
- Start
- 2007-06
- Primary completion
- 2008-04
- Completion
- 2008-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Phentermine | Small molecule | 15 mg | — |
| Subject | Topiramate | Small molecule | 100 mg | — |